The American Heart Association’s Scientific Sessions 2018 concluded this past Monday. Unfortunately I was unable to attend in-person, but I was able to catch some of the events virtually online via Scientific Sessions Live Streaming. While I have been to other scientific meetings hosted by the AHA, I have yet to attend the main event – Scientific Sessions. By live-streaming some of the sessions at the event, I was still able to hear about breaking scientific advances.
If you’ve ever felt like all of your colleagues were at a conference and you should have been there, but were prevented for whatever reason, that’s how I felt. Live-streaming some sessions at Scientific Sessions was a last-minute decision for me, but well worth it. I was able to watch Dr. Paul Ridker’s presentation at the AHA Distinguished Scientist Lecture. Not only did that provide the opportunity to hear Dr. Ridker’s update on new and exciting findings coming out of the CANTOS trial, I had never heard him speak until that moment. This was an opportunity I did not want to miss.
Another great opportunity that Live Streaming provided was the opportunity to connect in real-time with attendees who were at the Scientific Sessions in-person. As part of AHA’s Early Career Blogger team, I was able to live-tweet during the session and connect with other’s in the audience. It was a really great way to hear and feel connected to the cutting-edge science without being physically present.
This is my first blog post for the AHA Early Career Blogging team, so thanks for reading. My other posts will focus more on science in the fields of vascular biology and atherosclerosis, so if you’re interested, please stay tuned.